本页面由Tiger Trade Technology Pte. Ltd.提供服务

AEON Biopharma

0.2456
-0.0304-11.01%
盘后:0.25090.0053+2.16%19:53 EDT
成交量:108.21万
成交额:28.02万
市值:1,225.12万
市盈率:-0.07
高:0.2836
开:0.2741
低:0.2425
收:0.2760
52周最高:1.45
52周最低:0.1772
股本:4,988.28万
流通股本:3,050.95万
量比:0.56
换手率:3.55%
股息:- -
股息率:- -
每股收益(TTM):-3.5840
每股收益(LYR):-3.9532
净资产收益率:--
总资产收益率:-141.53%
市净率:-0.80
市盈率(LYR):-0.06

数据加载中...

2024/07/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/09

SEC问询函

Form CORRESP - Correspondence
2024/07/09

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/31

SEC问询函

Form CORRESP - Correspondence
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/19

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]